uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 6, 2019

FDA Warns Consumers Not to Use Certain Sexual Enhancement Supplements

On January 28, 2019, the FDA warned consumers not to buy or use the following sexual enhancement supplements were found to contain undeclared sildenafil and/or tadalafil. Use the links below to read the complete warning letter for each: Sildenafil, the active ingredient in the prescription drug Viagra, and tadalafil, the active ingredient in Cialis, are prescribed for erectile dysfunction. These drugs can cause symptoms like headache and flushing, and can interact with medications containing nitrates such as nitroglycerine, resulting in dangerously low blood pressure.

Consumers who have purchased these supplements should not use them and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Voluntary Reporting Program.

(See's Review of Sexual Enhancement Supplements for tests of related products.)

See related warnings:

Sexual Enhancement Supplements Contain Prescription Drugs

Sexual Enhancement Supplements Found to Contain Drugs

Sexual Enhancement Supplements for Men and Women Recalled

Twenty-one Sexual Enhancement Products Recalled

For more recalls and warnings, use the link below: